Preliminary cross-sectional evidence has also shown that liver fat content (as assessed by proton spectroscopy) may be the principal factor explaining the daily amount of insulin required to achieve good glycaemic control in patients with insulin-treated T2DM [11]. The gene discussed is INS; the disease is type 2 diabetes mellitus.